Deina H. Walsh - 08 Jan 2026 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Chief Financial Officer
Signature
/s/ Deina Walsh
Issuer symbol
BBLG
Transactions as of
08 Jan 2026
Net transactions value
$0
Form type
4
Filing time
21 Jan 2026, 16:37:14 UTC
Previous filing
21 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Walsh Deina H Chief Financial Officer C/O BONE BIOLOGICS CORP,, 2 BURLINGTON WOODS DR. SUITE 100, BURLINGTON, /s/ Deina Walsh 20 Jan 2026 0001651572

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BBLG Common Stock 313 08 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Employee Stock Option Award $0 +8,335 $0.000000 8,335 08 Jan 2026 Common Stock 8,335 $1.55 Direct F1
holding BBLG Employee Stock Option 4,510 08 Jan 2026 Common Stock 4,510 $5.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
F2 This option is fully vested as of the date of this report.